Natural Products from Echinacea purpurea
Natural Products Isolated from Echinacea purpurea
BioCrick provides high-purity natural products and bioactive compounds isolated and purified from natural sources for scientific research.
- Natural product compounds selected from diverse chemical and biological sources.
- Broad structural diversity and coverage of biological activities.
- Product activity information can be supported by published literature, patents and research reports.
- Natural products can be selected according to source, target, activity and disease research interests.
- Compounds should be stored according to the product specifications after receipt.
Natural Products from Echinacea purpurea
4 natural product s associated with Echinacea purpurea
| Catalog No. | Product Name | CAS Number | COA |
|---|---|---|---|
| BCC8275 |
(1R)-(+)-Alpha-Pinene
|
7785-70-8 | COA |
| BCN2096 |
Caftaric acid
|
67879-58-7 | COA |
| BCN9033 |
Cichoric acid
|
6537-80-0 | COA |
| BCN4953 |
Echinacoside
|
82854-37-3 | COA |
References
The effects of the dietary supplementation of Echinacea purpurea extract and/or vitamin C on the intestinal histomorphology, phagocytic activity, and gene expression of the Nile tilapia.[Pubmed: 30107260]
None
Cichoric Acid Prevents Free Fatty Acids Induced Lipid Metabolism Disorders via Regulating Bmal1 in HepG2 Cells.[Pubmed: 30036051]
Cichoric acid (CA), a polyphenol component from Echinacea purpurea, exhibits preventive effects on liver lipid metabolism disorders in obesity. This research aimed to determine the role of circadian rhythm signaling during the process of CA attenuated lipid accumulation in hepatocytes. In the current study, CA treatments improved cell morphology changes and hepatic lipid levels, which were triggered by free fatty acids (2:1, oleate: palmitate) in a dose dependent way. Besides, CA (200 μM) regulated the circadian rhythm expressions of clock genes and the relatively shallow daily oscillations. Moreover, silencing Bmal1 significantly blocked p-Akt/Akt pathway to 80.1% ± 1.5% and p-GSK3β/GSK3β pathway to 64.7% ± 2.8% (p < 0.05), and elevated the expressions of FAS and ACC to 122.4% ± 5.6% and 114.9% ± 1.7% in protein levels (p < 0.05), 166.5% ± 18.5% and 131.4% ± 5.5% in mRNA levels additionally (p < 0.05). Therefore, our results demonstrated that CA has a Bmal1 resistance to lipid accumulation by enhancing the Akt/GSK3β signaling pathways and modulating the downstream expressions related to lipid metabolism, which indicated that CA might be served as a natural and promising non-alcoholic fatty liver diseases (NAFLD) modulator.
Antagonism and antibiotic resistance drive a species-specific plant microbiota differentiation in Echinacea spp.[Pubmed: 29912319]
A key factor in the study of plant-microbes interactions is the composition of plant microbiota, but little is known about the factors determining its functional and taxonomic organization. Here we investigated the possible forces driving the assemblage of bacterial endophytic and rhizospheric communities, isolated from two congeneric medicinal plants, Echinacea purpurea (L.) Moench and Echinacea angustifolia (DC) Heller, grown in the same soil, by analysing bacterial strains (isolated from three different compartments, i.e. rhizospheric soil, roots and stem/leaves) for phenotypic features such as antibiotic resistance, extracellular enzymatic activity, siderophore and indole 3-acetic acid production, as well as cross-antagonistic activities. Data obtained highlighted that bacteria from different plant compartments were characterized by specific antibiotic resistance phenotypes and antibiotic production, suggesting that the bacterial communities themselves could be responsible for structuring their own communities by the production of antimicrobial molecules selecting bacterial-adaptive phenotypes for plant tissue colonization.